Kurt Von Emster, Director at CRISPR Therapeutics AG (CRSP), sold 2,920 shares at $12.51 ($23K) on 2018-06-05, disclosed to the SEC on 2018-06-07.
Open-market sale of $23k CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.75 | 2,000 | $12K | 50.0% |
| 2 | $12.51 | 920 | $12K | 50.0% |
| Total | $7.88 avg | 2,920 | $23K | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |